Row 76736

Row ID: 76736 | Dataset Entry | Axioma AXP Content Repository

Content Data

This page contains data entry 76736 from the Axioma AXP content repository. The structured data below represents the complete record for this entry.

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines.

The stock fell with 91% lately. Working backwards from analyst estimates, it turns out that they expect the company to grow 73% year-on-year.

Yesterday news came out that they are switching focus to a medicine for kidney disease. After the news Vivoryon gained about 59% yesterday and is 60%+ today as well.

A buy or nah?

FieldValue
text Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. The stock fell with 91% lately. Working backwards from analyst estimates, it turns out that they expect the company to grow 73% year-on-year. Yesterday news came out that they are switching focus to a medicine for kidney disease. After the news Vivoryon gained about 59% yesterday and is 60%+ today as well. A buy or nah?
label r/wallstreetbets
dataType post
communityName r/wallstreetbets
datetime 2024-05-24
username_encoded Z0FBQUFBQm5Lak1qek9tSUZyY2wwMzVOUzg3SUo1VXEybmxFY0szN09GLVB3Y1VJdlZPMHd2SnlMaWhIZXdBME04UVdGQldXd05EYV9rZXJwRklWa1JuRlZTOTBCMWpib1E9PQ==
url_encoded Z0FBQUFBQm5Lak96bnJaVnp4bEZTVmxuczhMb0Q4elpsVmdpTnlKQ2ZXVXFJNGZTMkV6Mk1wSk1Dcm5Id0JnRnpvTFFmcnZMWnZwOHBOWDJ1YlVOai1ScTRXMFE1QlAtV1JoVHlGYkVFdjVIQmpIUlJrY2swZWFibzROUUxPS19YeG1ZWnlqZURFM1VpRDJfZTlBQ2dCMDI2ZmkzNGgxUE5oVkdTTUVvcFdEZjRUclRoTmNmQWIwPQ==

Raw Record

{
  "text": "Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. \n\nThe stock fell with 91% lately. Working backwards from analyst estimates, it turns out that they expect the company to grow 73% year-on-year.\n\nYesterday news came out that they are switching focus to a medicine for kidney disease. After the news Vivoryon gained about 59% yesterday and is 60%+ today as well.\n\nA buy or nah?",
  "label": "r/wallstreetbets",
  "dataType": "post",
  "communityName": "r/wallstreetbets",
  "datetime": "2024-05-24",
  "username_encoded": "Z0FBQUFBQm5Lak1qek9tSUZyY2wwMzVOUzg3SUo1VXEybmxFY0szN09GLVB3Y1VJdlZPMHd2SnlMaWhIZXdBME04UVdGQldXd05EYV9rZXJwRklWa1JuRlZTOTBCMWpib1E9PQ==",
  "url_encoded": "Z0FBQUFBQm5Lak96bnJaVnp4bEZTVmxuczhMb0Q4elpsVmdpTnlKQ2ZXVXFJNGZTMkV6Mk1wSk1Dcm5Id0JnRnpvTFFmcnZMWnZwOHBOWDJ1YlVOai1ScTRXMFE1QlAtV1JoVHlGYkVFdjVIQmpIUlJrY2swZWFibzROUUxPS19YeG1ZWnlqZURFM1VpRDJfZTlBQ2dCMDI2ZmkzNGgxUE5oVkdTTUVvcFdEZjRUclRoTmNmQWIwPQ=="
}
Explore Dataset Explore Row

Entry Information